Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : All Clowns Must Be Destroyed -- Ignore unavailable to you. Want to Upgrade?

To: NickSE who wrote (11078)	2/18/2000 4:46:00 PM
From: MythMan	Read Replies (1) \| Respond to of 42523

>>mainly because home Web connection speeds pale in comparison to the faster connections that companies give their employees.<< No shirt -g- What town is the Bada Bing in, again?

To: NickSE who wrote (11078)	2/18/2000 4:47:00 PM
From: CYC	Respond to of 42523

Excellent commentary by Paul Kasriel of Northern Trust at ntrs.com I enjoyed reading the last weekly and the two daily of yesterday and today. Cheers.

To: NickSE who wrote (11078)	2/19/2000 10:55:00 AM
From: NickSE	Respond to of 42523

Biotech Investors Rewarded for Patience nytimes.com The Nasdaq Biotech Index, which includes more than 200 U.S. and European companies, is up over 60 percent for the first two months of this year, making it the Nasdaq's best performing group. What's more, the startling gains follow a 101 percent jump for the sector in 1999, a year in which investors finally sat up and took notice of terminology such as "the human genome," "genomics," and "gene expression." The biotech index is up 630 percent since early 1994. That eclipses a 275 percent gain for the average large U.S. drugmaker during those years and a 192 percent gain for the broad-based Standard & Poors 500 Index. It also overshadows a 424 percent gain for the Nasdaq Composite Index, which is full of Internet as well as biotech stocks. [...]